Search - tctmd.com

Displaying 341 - 360 of 491

Sort: Relevancy | Date

Presentation TCT 2018

The Watch TAVR Trial: Rationale, Design and Status

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Samir R. Kapadia

September 24, 2018

Presentation TCT 2018

The WaveCrest Device and US Pivotal Trial

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Gregg W. Stone

September 24, 2018

Presentation TCT 2018

The Amulet Platform, Experience and US Pivotal Trial

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Apostolos Tzikas

September 24, 2018

Presentation TCT 2018

The Watchman Platform, ASAP Too and Flex: Rationale, Device and Overview of the Trials

Presenter: Vivek Y. Reddy, Brian K. Whisenant

September 24, 2018

Presentation TCT 2018

FDA Perspectives on New Devices and Indications for LAA Closure

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Andrew Farb

September 24, 2018

Presentation TCT 2018

The LAAO Registry: Overview, Data Adjudication, and Emerging Insights

Presenter: Vivek Y. Reddy, Brian K. Whisenant, Paul D. Varosy

September 24, 2018

Presentation TCT 2018

Managing a Busy LAA Closure Program: Patient Selection, Education, Consent, Screening, and Periprocedural Care

Presenter: James B. Hermiller Jr, David Hildick-Smith, George S. Hanzel

September 24, 2018

Presentation TCT 2018

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Presenter: James B. Hermiller Jr, David Hildick-Smith, Martin W. Bergmann

September 24, 2018

Presentation TCT 2018

Essential of Pre-procedural Imaging and Intra-procedural Guidance

Presenter: James B. Hermiller Jr, David Hildick-Smith, Jacqueline Saw

September 24, 2018

Presentation TCT 2018

Shared Decision-making in NVAF: The Patients Perspective

Presenter: James B. Hermiller Jr, David Hildick-Smith, Megan Coylewright

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr.

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Presenter: James B. Hermiller Jr, David Hildick-Smith, Freek W.A. Verheugt

September 24, 2018

Presentation TCT 2018

Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective

Presenter: James B. Hermiller Jr, David Hildick-Smith, David E. Thaler

September 24, 2018

Presentation TCT 2018

A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC?

Presenter: Zahid Amin, Robert J. Sommer, Peter C. Block, John P. Breinholt, Craig E Fleishman, Jan Kovac, Harsimran Sachdeva Singh, Christian Spies

September 24, 2018

Presentation TCT 2018

TAVI/LAAO: A Randomized Trial of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation

Presenter: Horst Sievert, Brian K. Whisenant, Fabian Nietlispach

September 23, 2018

Presentation TCT 2018

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

Presenter: Anibal A. Damonte

September 21, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

Manuscript

Unexpected Murmur after Percutaneous Left Atrial Appendage Occlusion

September 05, 2018

News Conference News ESC 2018

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

Michael O'Riordan

August 25, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

Advertisement

The Watch TAVR Trial: Rationale, Design and Status

The WaveCrest Device and US Pivotal Trial

The Amulet Platform, Experience and US Pivotal Trial

The Watchman Platform, ASAP Too and Flex: Rationale, Device and Overview of the Trials

FDA Perspectives on New Devices and Indications for LAA Closure

The LAAO Registry: Overview, Data Adjudication, and Emerging Insights

Managing a Busy LAA Closure Program: Patient Selection, Education, Consent, Screening, and Periprocedural Care

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Essential of Pre-procedural Imaging and Intra-procedural Guidance

Shared Decision-making in NVAF: The Patients Perspective

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective

A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC?

TAVI/LAAO: A Randomized Trial of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation

TAVR in the Patient With Atrial Fibrillation and Contraindications to Chronic Anticoagulation

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Unexpected Murmur after Percutaneous Left Atrial Appendage Occlusion

Atrial Fibrillation, Oral Anticoagulation Linked With Mortality After TAVR: FRANCE-TAVI

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content